One May 26,The Journal of the American Medical Association, JAMA，IF45.54 published the “Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults” by China National Biotec Group(CNBG) of China National Pharmaceutical Group Co., Ltd. (Sinopharm).The report summarizes and analyzes the effectiveness and safety of the Phase III clinical trial of the novel crown inactivated vaccine (Ⅲ) from Beijing Institute of Biological Products (BIBP), Wuhan Institute of Biological Products (WIBP) of China National Biotec Group(CNBG) Phase III of the new crown inactivated vaccines.